Dr. Luis L. Mas , MD
General Practice • Miami, FL
42 Nw 27th Ave, Suite # 401
Miami, FL 331255127
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 18, 2006; this date does not establish years in practice.
-
Published CMS data list 2,823 Medicare Part D prescriptions, including refills, in 2018.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2018. Published rows only; this is not a quality measure.
-
Published Part D records, 2018:
- Vitamin D2 (Ergocalciferol (Vitamin D2)) — 134 prescription fills, including refills.
- Gabapentin — 118 prescription fills, including refills.
- Alendronate Sodium — 112 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2018. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 81 records in the table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 81 in 2014 to 2,823 in 2018.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2014–2018.
Practice Location & Contact Primary Location
42 Nw 27th Ave
Suite # 401
Miami, FL 331255127
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
3,061 standardized 30-day fills in 2018
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$159,538 in 2018
The total cost of these prescriptions in 2018, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2018.
Industry payments (Open Payments)
15 payment records totaling $1,773.85 in 2025
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
Research: payments made under a research agreement. They may go to an institution rather than the clinician.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2025.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Mas has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Mas as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Mas are from 2018.
285 active clinicians are listed under General Practice with a practice address in Miami, FL (2,293 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Miami
9.1% of these 285 clinicians have the CMS telehealth indicator.
42.8% of these 285 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 3385% from 81 in 2014 to 2,823 in 2018.
- 2014: 81
- 2015: 25
- 2016: 37
- 2017: 1,150
- 2018: 2,823
-
30-day fills
30-day fills increased 3339% from 89 in 2014 to 3,061 in 2018.
- 2014: 89
- 2015: 25
- 2016: 37
- 2017: 1,239
- 2018: 3,061
-
Part D drug cost
Part D drug cost increased 3728% from $4,168 in 2014 to $159,538 in 2018.
- 2014: $4,168
- 2015: $89
- 2016: $569
- 2017: $30,916
- 2018: $159,538
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $246.87 in 2019 to $1,773.85 in 2025.
- 2019: $246.87
- 2021: $24.45
- 2023: $1,987.47
- 2025: $1,773.85
Sources: CMS Medicare Part D Prescribers (2018), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 15 records totaling $1,773.85.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $293.25 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $293.25 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $264.84 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $253.82 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $124.16 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $79.69 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $73.00 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $62.49 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $59.81 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $53.88 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $50.41 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $46.76 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $45.71 |
| GlaxoSmithKline, LLC. |
General
In-kind items and services
|
— | Research | $38.53 |
| GlaxoSmithKline, LLC. |
General
Cash or cash equivalent
|
— | Research | $34.25 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2018.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 134 | 4,020 | $264.55 | 24 |
| Gabapentin | Gabapentin | 118 | 3,765 | $1,446.02 | 25 |
| Alendronate Sodium | Alendronate Sodium | 112 | 3,354 | $578.06 | 16 |
| Losartan Potassium | Losartan Potassium | 104 | 3,635 | $675.73 | 24 |
| Atorvastatin Calcium | Atorvastatin Calcium | 101 | 3,131 | $777.38 | 25 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 96 | 3,000 | $12,469.36 | 25 |
| Lisinopril | Lisinopril | 94 | 3,060 | $424.35 | 19 |
| Metformin Hcl | Metformin Hcl | 94 | 3,360 | $456.84 | 24 |
| Ibuprofen | Ibuprofen | 92 | 2,739 | $422.10 | 29 |
| Diclofenac Sodium | Diclofenac Sodium | 71 | 2,193 | $1,909.20 | 24 |
| Omeprazole | Omeprazole | 67 | 2,010 | $1,375.02 | 23 |
| Ranitidine Hcl | Ranitidine Hcl | 59 | 1,825 | $232.15 | 14 |
| Furosemide | Furosemide | 58 | 1,840 | $209.44 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 55 | 1,890 | $802.08 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 51 | 1,950 | $522.57 | 13 |
| Donepezil Hcl | Donepezil Hcl | 51 | 1,800 | $408.59 | 17 |
| Montelukast Sodium | Montelukast Sodium | 50 | 1,500 | $630.94 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 49 | 1,470 | $868.01 | 12 |
| Amlodipine Besylate | Amlodipine Besylate | 42 | 1,320 | $186.88 | — |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 42 | 400 | $732.16 | 34 |
| Alprazolam | Alprazolam | 41 | 1,260 | $314.75 | 13 |
| Simvastatin | Simvastatin | 36 | 1,200 | $182.95 | — |
| Levothyroxine Sodium | Levothyroxine Sodium | 36 | 1,074 | $354.48 | — |
| Cholestyramine Light | Cholestyramine/Aspartame | 36 | 1,080 | $3,674.73 | — |
| Allopurinol | Allopurinol | 34 | 1,080 | $274.91 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2018; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - GENERAL PRACTICE
I20041012001186
FL
0143280412
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Specialist
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated July 18, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other General Practices in Miami
- Dr. Ana Solis, MD
- Dr. Maytee Diaz Torres, MD
- Dr. Armando Villanueva Ramos, MD
- Dr. Miguel Nunez, MD
- Dr. Francisco Delgado, MD
- Dr. Ilsys Martinez, MD
Mailing Address
15106 Sw 20th Ln
Miami, FL 331855679
Phone: 3054017451